What Is the JC Virus? The John Cunningham virus, known more commonly as the JC virus, is a very common virus in the United States. According to the World Journal of Neurosciences, between 70 and 90 percent of people in the world have the virus. The average person carrying the JC virus will never know and is unlikely to suffer any side effects as a result of its being in his or her body.  However, for a small percentage of individuals with multiple sclerosis (MS), that is not the case. The…

The JC Virus and Risks for MS Patients

What Is the JC Virus? The John Cunningham virus, known more commonly as the JC virus, is a very common virus in the United States. According to the World Journal of Neurosciences, between 70 and 90 percent of people in the world have the virus. The average person carrying the JC virus will never know and is unlikely to suffer any side effects as a result of its being in his or her body. However, for a small percentage of individuals with multiple sclerosis (MS), that is not the case. The…

Understanding the JC Virus and the Risks for MS Patients Learn how an extremely common and normally harmless virus may put certain multiple sclerosis patients at risk for some dangerous complications and what you should discus with your doctor before starting treatment.

The JC Virus and Risks for MS Patients

Understanding the JC Virus and the Risks for MS Patients Learn how an extremely common and normally harmless virus may put certain multiple sclerosis patients at risk for some dangerous complications and what you should discus with your doctor before starting treatment.

More Natalizumab Patients Turn Positive for JC Virus Antibodies | Medpage Today

More Natalizumab Patients Turn Positive for JC Virus Antibodies

More Natalizumab Patients Turn Positive for JC Virus Antibodies | Medpage Today

"I am always concerned for the PML risk" this new study shocks me at how fast you can develop from JVC- to JCV+" ~Lynne A case of progressive multifocal leukoencephalopathy (PML) associated with natalizumab (Tysabri, Biogen) therapy has been reported in a patient with multiple sclerosis (MS) who***** had tested negative for JC virus (JCV) antibodies just 2 weeks before symptoms developed.****  1-15-2016

"I am always concerned for the PML risk" this new study shocks me at how fast you can develop from JVC- to JCV+" ~Lynne A case of progressive multifocal leukoencephalopathy (PML) associated with natalizumab (Tysabri, Biogen) therapy has been reported in a patient with multiple sclerosis (MS) who***** had tested negative for JC virus (JCV) antibodies just 2 weeks before symptoms developed.**** 1-15-2016

Researchers May Have Found Answer To Defeat JC Virus And Eliminate PML!

Researchers May Have Found Answer To Defeat JC Virus And Eliminate PML!

A number of recent studies have investigated the proportion of people with #MS who have been exposed to the JC virus. JC virus exposure is one of the risk factors for developing PML (progressive multifocal leukoencephalopathy) during treatment with Tysabri. Read more: http://msology.ca/how-common-is-jc-virus-exposure-2

A number of recent studies have investigated the proportion of people with #MS who have been exposed to the JC virus. JC virus exposure is one of the risk factors for developing PML (progressive multifocal leukoencephalopathy) during treatment with Tysabri. Read more: http://msology.ca/how-common-is-jc-virus-exposure-2

Stephanie explains progressive multifocal leukoencephalopathy (PML) and the John Cunningham Virus (JCV) and their relationship to MS.

Stephanie explains progressive multifocal leukoencephalopathy (PML) and the John Cunningham Virus (JCV) and their relationship to MS.

JC Virus Vaccination Might Have Important Implications For Multiple Sclerosis Patients

JC Virus Vaccination Might Have Important Implications For Multiple Sclerosis Patients

Possible JC Virus Vaccination Offers Important Implications for MS Treatment

This MRI image of a person with natalizumab-associated PML shows a large lesion in the right hemisphere of the brain. PML kills myelinmaking oligodendrocytes and other brain cells, destroying white matter. The JC virus can also infect and damage gray matter, causing other destructive acute diseases. Image courtesy of Dr. A. Valavanis, Dept. of Neuroradiology, University Hospital Zurich.

This MRI image of a person with natalizumab-associated PML shows a large lesion in the right hemisphere of the brain. PML kills myelinmaking oligodendrocytes and other brain cells, destroying white matter. The JC virus can also infect and damage gray matter, causing other destructive acute diseases. Image courtesy of Dr. A. Valavanis, Dept. of Neuroradiology, University Hospital Zurich.

Living with Multiple Sclerosis - JC virus and PML.mpg

Living with Multiple Sclerosis - JC virus and PML.mpg

Pinterest
Search